Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (2) Janz, Martin Dr. (6) Kammertöns, Thomas Dr. (3) Leisegang, Matthias Prof. Dr. rer. nat. (1) Leutz, Achim Prof. Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (6) Pezzutto, Antonio Prof. Dr. (2) Scheidereit, Claus Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (4) Willimsky, Gerald Dr. (4) (-) Blankenstein, Thomas Prof. Dr. (11) (-) Kopp, Joachim Dr. (1) (-) Selbach, Matthias Prof. Dr. (6) (-) Wollert-Wulf, Brigitte (2) (-) Biologie maligner Lymphome (2) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (11) (-) Proteom Dynamik (6) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (4) 2000 (8) 2001 (8) 2002 (8) 2003 (10) 2004 (10) (-) 2005 (14) (-) 2006 (5) 2007 (6) 2008 (8) 2009 (8) 2010 (10) 2011 (12) 2012 (10) 2013 (17) 2014 (15) 2015 (14) 2016 (12) 2017 (12) 2018 (10) 2019 (11) 2020 (6) 2021 (16) 2022 (16) 2023 (10) 2024 (4) 19 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Kopp, Joachim Dr.Selbach, Matthias Prof. Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Immunologie und Gentherapie Proteom Dynamik20052006 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 20. Mai 2005 / Bioforum Gentherapie mit T-Zellrezeptor modifizierten Zellen W. Uckert T. Blankenstein 01. Juli 2005 / Hum Gene Ther Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes B. Engels E. Noessner B. Frankenberger T. Blankenstein D.J. Schendel W. Uckert 05. Juli 2005 / World J Urol Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells B. Frankenberger S. Regn C. Geiger E. Noessner C.S. Falk H. Pohla M. Javorovic T. Silberzahn S. Wilde A. Buchner M. Siebels R. Oberneder G. Willimsky A. Pezzutto T. Blankenstein D.J. Schendel 01. September 2005 / Nature Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance G. Willimsky T. Blankenstein 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Januar 2005 / Int J Cancer Tumor-induced antibodies resemble the response to tissue damage S. Preiss T. Kammertoens C. Lampert G. Willimsky T. Blankenstein 01. Januar 2005 / Curr Opin Immunol The role of tumor stroma in the interaction between tumor and immune system T. Blankenstein 01. Januar 2005 / Clin Cancer Res Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs B. Frankenberger H. Pohla E. Noessner G. Willimsky B. Papier A. Pezzutto J. Kopp R. Oberneder T. Blankenstein D.J. Schendel Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
20. Mai 2005 / Bioforum Gentherapie mit T-Zellrezeptor modifizierten Zellen W. Uckert T. Blankenstein
01. Juli 2005 / Hum Gene Ther Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes B. Engels E. Noessner B. Frankenberger T. Blankenstein D.J. Schendel W. Uckert
05. Juli 2005 / World J Urol Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells B. Frankenberger S. Regn C. Geiger E. Noessner C.S. Falk H. Pohla M. Javorovic T. Silberzahn S. Wilde A. Buchner M. Siebels R. Oberneder G. Willimsky A. Pezzutto T. Blankenstein D.J. Schendel
01. September 2005 / Nature Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance G. Willimsky T. Blankenstein
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Januar 2005 / Int J Cancer Tumor-induced antibodies resemble the response to tissue damage S. Preiss T. Kammertoens C. Lampert G. Willimsky T. Blankenstein
01. Januar 2005 / Curr Opin Immunol The role of tumor stroma in the interaction between tumor and immune system T. Blankenstein
01. Januar 2005 / Clin Cancer Res Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs B. Frankenberger H. Pohla E. Noessner G. Willimsky B. Papier A. Pezzutto J. Kopp R. Oberneder T. Blankenstein D.J. Schendel